Abingdon Health (LON:ABDX) Sets New 52-Week Low – What’s Next?

Abingdon Health Plc (LON:ABDX)’s stock price hit a new 52-week low during trading on Friday . The stock traded as low as GBX 6 ($0.08) and last traded at GBX 6.36 ($0.08), with a volume of 168397 shares changing hands. The stock had previously closed at GBX 6.50 ($0.08).

Abingdon Health Price Performance

The company has a 50 day simple moving average of GBX 7.40 and a 200-day simple moving average of GBX 7.93. The stock has a market cap of £12.31 million, a price-to-earnings ratio of -15.46 and a beta of 0.13. The company has a current ratio of 1.95, a quick ratio of 1.96 and a debt-to-equity ratio of 46.64.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Monday, March 24th. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.